204 related articles for article (PubMed ID: 18804334)
1. Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: a systematic review.
Bekelman JE; Yahalom J
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):492-8. PubMed ID: 18804334
[TBL] [Abstract][Full Text] [Related]
2. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
Müller RP; Eich HT
Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
[TBL] [Abstract][Full Text] [Related]
3. Quality of radiotherapy reporting in randomized controlled trials of prostate cancer.
Soon YY; Chen D; Tan TH; Tey J
Radiat Oncol; 2018 Jun; 13(1):108. PubMed ID: 29880015
[TBL] [Abstract][Full Text] [Related]
4. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
5. Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).
Fitzgerald TJ; Bishop-Jodoin M; Cicchetti MG; Hanusik R; Kessel S; Laurie F; McCarten KM; Moni J; Pieters RS; Rosen N; Ulin K; Urie M; Chauvenet AR; Constine LS; Deye J; Vikram B; Friedman D; Marcus RB; Mendenhall NP; Williams JL; Purdy J; Saltz J; Schwartz CL; White KS; Wolden S
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):315-6. PubMed ID: 20394859
[No Abstract] [Full Text] [Related]
6. Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.
Eich HT; Engenhart-Cabillic R; Hansemann K; Lukas P; Schneeweiss A; Seegenschmiedt H; Skripnitchenko R; Staar S; Willich N; Müller RP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1419-24. PubMed ID: 18234433
[TBL] [Abstract][Full Text] [Related]
7. Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology.
Tsang RW; Gospodarowicz MK; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):643-51. PubMed ID: 11849785
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
[TBL] [Abstract][Full Text] [Related]
9. New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.
Kriz J; Baues C; Engenhart-Cabillic R; Haverkamp U; Herfarth K; Lukas P; Schmidberger H; Marnitz-Schulze S; Fuchs M; Engert A; Eich HT
Strahlenther Onkol; 2017 Feb; 193(2):100-108. PubMed ID: 27678010
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for Hodgkin's lymphoma: too hard to die?
Zygogianni AG; Kyrgias G; Psyrri A; Kantzou I; Koumarianou A; Tolia M; Tsekeris P; Tsirigotis P; Sarris G; Kouvaris J; Kouloulias V
J BUON; 2012; 17(1):116-23. PubMed ID: 22517704
[TBL] [Abstract][Full Text] [Related]
11. The radiotherapy reference panel--experiences and results of the German Hodgkin Study Group (GHSG).
Eich HT; Müller RP
Eur J Haematol Suppl; 2005 Jul; (66):98-105. PubMed ID: 16007876
[TBL] [Abstract][Full Text] [Related]
12. [Radiation therapy for malignant lymphoma].
Ito Y; Ishikura S; Ogino T; Ikeda H
Nihon Rinsho; 2000 Mar; 58(3):709-14. PubMed ID: 10741151
[TBL] [Abstract][Full Text] [Related]
13. Lymphoma cases referred to the radiation oncology service of a tertiary referral university hospital in Karachi, Pakistan: a retrospective study.
Abbasi AN; Zahid S; Karsan F; Ali N; Bhurgri Y
Asian Pac J Cancer Prev; 2010; 11(1):107-10. PubMed ID: 20593938
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy treatment of lymphoma].
Juretić A; Zivković M; Samija M; Cović D; Bistrović M; Viculin T; Bagović D; Tomek R
Lijec Vjesn; 2000; 122(11-12):283-91. PubMed ID: 11291272
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
17. Importance of PET/CT scan use in planning radiation therapy for lymphoma.
Milana MA; Marko E; Miroslav L; Tihomir D
Asian Pac J Cancer Prev; 2015; 16(5):2051-4. PubMed ID: 25773849
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy of Hodgkin's and non-Hodgkin's lymphomas. Indications, techniques and outcome].
Engenhart-Cabillic R; Debus J; Wannenmacher M
Radiologe; 1997 Jan; 37(1):81-8. PubMed ID: 9157480
[TBL] [Abstract][Full Text] [Related]
19. Treatment planning for Hodgkin's disease: a patterns of care study.
Hughes DB; Smith AR; Hoppe R; Owen JB; Hanlon A; Wallace M; Hanks GE
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):519-24. PubMed ID: 7673042
[TBL] [Abstract][Full Text] [Related]
20. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
